ZP 80mg Tablet

Introduction

ZP is a medication containing the active ingredient Zaltoprofen. It is used for relieving pain and inflammation.

Uses

ZP is prescribed for the treatment of conditions involving pain and inflammation, such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis.

Dosage and Administration

The general dosage of ZP is 80 mg once daily. It is usually administered orally with water, preferably after meals to minimize stomach upset.

Mechanism of Action

Zaltoprofen, the active ingredient in ZP, works by inhibiting the production of certain substances in the body that are responsible for pain and inflammation. This helps in reducing pain and swelling associated with various conditions.

Side Effects

Common side effects of ZP may include nausea, indigestion, and stomach pain. Serious side effects such as severe allergic reactions, stomach bleeding, and liver problems are rare but possible. If any serious side effects occur, immediate medical attention should be sought.

Drug Interactions

ZP may interact with other medications such as aspirin, other NSAIDs, and blood thinners. These interactions can increase the risk of side effects or affect the effectiveness of either medication. Inform the healthcare provider about all the medications being taken to avoid potential interactions.

Precautions

Patients with a history of stomach ulcers, kidney problems, or allergic reactions to NSAIDs should use ZP with caution. Avoid alcohol consumption while taking this medication, as it can increase the risk of stomach bleeding.

Storage

Patient Tips

• It is advisable to take ZP with food to minimize the risk of stomach upset.
• If any unusual symptoms or side effects occur while taking this medication, consult a healthcare professional promptly.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Jia L, Hu C, Wang H, Liu Y, Liu X, Zhang YY, Li W, Wang LX, Cao YF, Fang ZZ. Chirality Influence of Zaltoprofen Towards UDP-Glucuronosyltransferases (UGTs) Inhibition Potential. Chirality. 2015 Jun;27(6):359-63. doi: 10.1002/chir.22436. Epub 2015 Apr 22. [Accessed 15 Jun. 2024] Available at:
• Sadasivam B, Jhaj R, Kumar S, Pathan S, Chenchula S. Anti-inflammatory and arthritic activity of zaltoprofen compared to piroxicam in murine models. Bioinformation. 2022 Sep 30;18(9):752-756. doi: 10.6026/97320630018752. eCollection 2022. [Accessed 10 Jun. 2024] Available at:
• Okamoto T. NSAID zaltoprofen improves the decrease in body weight in rodent sickness behavior models: proposed new applications of NSAIDs (Review). Int J Mol Med. 2002 Apr;9(4):369-72. [Accessed 30 Jun. 2024] Available at:
• Higuchi T, Takeuchi A, Munesue S, Yamamoto N, Hayashi K, Harashima A, Yamamoto Y, Tsuchiya H. A nonsteroidal anti-inflammatory drug, zaltoprofen, inhibits the growth of extraskeletal chondrosarcoma cells by inducing PPARgamma, p21, p27, and p53. Cell Cycle. 2023 Apr;22(8):939-950. doi: 10.1080/15384101.2023.2166195. Epub 2023 Jan 12. [Accessed 11 Jun. 2024] Available at: